Sponsored Links
| Avastin Phase III Study Shows Positive Results In Women With Advanced Ovarian Cancer |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a phase III study showed the combination of Avastin (bevacizumab) and chemotherapy followed by maintenance use of Avastin increased the time women with advanced ovarian cancer lived without their disease worsening (progression-free survival or PFS) compared to chemotherapy alone... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|